Skip to main content
SpringerLink
Log in

TLR Polymorphisms in FMF: Association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) Polymorphisms and Myeloid Cell TLR-2 and TLR-4 Expression with the Development of Secondary Amyloidosis in FMF

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Amyloidosis is the major complication of familial Mediterranean fever (FMF). Toll-like receptors (TLR) are involved in the activation of an innate immune system TLR-2 and TLR-4 recognize lipoteichoic acid and lipopolysaccharides (LPS), respectively. While TLR-2 Arg753Gln polymorphism upregulates, TLR-4 Asp299Gly and Thre399Ile polymorphisms downregulate inflammation. We investigated the effect of these polymorphisms on the development of amyloidosis in FMF patients. We also investigated myeloid cell TLR-2 and TLR-4 expressions in these patients. We studied 26 FMF patients and 13 FMF patients with amyloidosis. TLR-2 Arg753Gln and TLR-4 Asp299Gly and Thr399Ile polymorphisms were analyzed with the polymerase chain reaction-restriction fragment length polymorphism method. Myeloid cell baseline TLR-2 and TLR-4 and LPS-induced TLR-4 expressions were evaluated. The TLR-2 and TLR-4 polymorphism rate was compared with the results of 100 healthy subjects in our previous study. In addition, 13 healthy controls were enrolled for leukocyte TLR-2 and TLR-4 expressions. Serum amyloid A (SAA) levels were measured in these 13 control cases and in FMF patients during attack-free periods. The frequency of TLR-2 Arg753Gln, TLR-4 Asp299Gly, and Thr399Ile polymorphisms in healthy controls in our previous study were 1%, 3%, and 2%, respectively. The frequency of these polymorphisms were not different in FMF patients (with or without amyloidosis) compared to the control group. Likewise, myeloid cell TLR-2 and TLR-4 expressions were not different among the controls and FMF patients. However, LPS-induced TLR-4 expression in granulocytes was more prominent in FMF patients. There was no correlation between TLR-2 and TLR-4 expressions and SAA levels. Neither myeloid cell TLR-2 and TLR-4 expressions nor TLR-3 Arg753Gln, TLR-4 Asp299Gly, and Thr399Ile polymorphisms seem to affect the development of secondary amyloidosis in FMF patients in our study population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

REFERENCES

  1. Tunca, M., S. Akar, F. Onen, et al. 2005. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine (Baltimore) 84: 1–11.

    Article  Google Scholar 

  2. Centola, M., G. Wood, D.M. Frucht, et al. 2000. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95: 3223–3231.

    PubMed  CAS  Google Scholar 

  3. Bagci, S., B. Toy, A. Tuzun, et al. 2004. Continuity of cytokine activation in patients with familial Mediterranean fever. Clinical Rheumatology 23: 333–337.

    Article  PubMed  Google Scholar 

  4. Oktem, S., T.U. Yavuzsen, B. Sengul, H. Akhunlar, S. Akar, and M. Tunca. 2004. Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever patients and their first degree relatives. Clinical and Experimental Rheumatology 22(Suppl 34): S34–S36.

    PubMed  CAS  Google Scholar 

  5. Yamada, T., Y. Okuda, and Y. Itoh. 1998. The frequency of serum amyloid A2 alleles in the Japanese population. Amyloid 5: 208–211.

    Article  PubMed  CAS  Google Scholar 

  6. Ben-Chetrit, E. 2003. Familial Mediterranean fever (FMF) and renal AA amyloidosis: Phenotype-genotype correlation, treatment and prognosis. Journal of Nephrology 16: 431–434.

    PubMed  CAS  Google Scholar 

  7. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Inter Immunol 17: 1–14.

    Article  CAS  Google Scholar 

  8. Schroder, N.W.J., and R.R. Schumann. 2005. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. The Lancet Infectious Diseases 5: 156–164.

    PubMed  Google Scholar 

  9. Samuelsson, P., L. Hang, B. Wullt, H. Irjala, and C. Svanborg. 2004. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infection and Immunity 72(6): 3179–3186.

    Article  PubMed  CAS  Google Scholar 

  10. Cook, D.N., D.S. Pisetsky, and D.A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nature Immunology 5: 975–979.

    Article  PubMed  CAS  Google Scholar 

  11. Berdeli, A., H.A. Celik, R. Ozyurek, B. Dogrusoz, and H.H. Aydin. 2005. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. Journal of Molecular Medicine 83: 535–541.

    Article  PubMed  CAS  Google Scholar 

  12. Ozen, S., A. Berdeli, B. Türel, et al. 2006. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: Linking the environment to the phenotype in a monogenic inflammatory disease. The Journal of Rheumatology 33: 2498–2500.

    PubMed  CAS  Google Scholar 

  13. Montes, A.H., V. Asensi, V. Alvarez, et al. 2006. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis. Clinical and Experimental Immunology 143: 404–413.

    Article  PubMed  CAS  Google Scholar 

  14. Arbour, N.C., E. Lorenz, B.C. Schutte, et al. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics 25: 187–191.

    Article  PubMed  CAS  Google Scholar 

  15. Schmitt, A. Humeny, C.M. Becker, K. Brune, and A. Pahl. 2002. Polymorphisms of TLR4: Rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clinical Chemistry 48: 1661–1667.

    PubMed  CAS  Google Scholar 

  16. Ferwerda, B., M.B. McCall, S. Alonso, et al. 2007. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proceedings of the National Academy of Sciences of the United States of America 104: 16645–16650.

    Article  PubMed  Google Scholar 

  17. Livneh, A., P. Langevitz, D. Zemer, S. Kees, and T. Lidar. 1997. Criteria for the diagnosis of familial Mediterranean fever. Arthritis and Rheumatism 40: 1879–1885.

    Article  PubMed  CAS  Google Scholar 

  18. Soylu, A., S. Kızıldağ, S. Kavukçu, S. Cingöz, M. Türkmen, B. Kasap Demir, and M. Sakızlı. 2010. TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in Henoch Schonlein purpura with and without renal involvement. Rheumatology International 30: 667–670.

    Article  PubMed  CAS  Google Scholar 

  19. Brandl, K., T. Gluck, C. Huber, B. Salzberger, W. Falk, and P. Hartmann. 2005. TLR-4 surface display on human monocytes is increased in septic patients. European Journal of Medical Research 10: 319–324.

    PubMed  CAS  Google Scholar 

  20. Schroder, N.W., C. Heran, L. Hamann, U.B. Gobel, T. Hartung, and R.R. Schumann. 2003. High frequency of polymorphism Arg753Gln of the Tollike rceptor-2 gene detected by a novel allele-specific PCR. Journal of Molecular Medicine 81: 368–372.

    PubMed  Google Scholar 

  21. Lorenz, E., K.L. Frees, and D.A. Schwartz. 2001. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 31: 22–24.

    PubMed  CAS  Google Scholar 

  22. Samuels, J., I. Aksentijevich, Y. Torosyan, et al. 1998. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 77: 268–297.

    Article  CAS  Google Scholar 

  23. Cattan, D. 2005. MEFV mutation carriers and diseases other than familial Mediterranean feer: Proved and non-proved associations; putative biological advantage. Current Drug Targets. Inflammation and Allergy 4: 105–112.

    Article  PubMed  CAS  Google Scholar 

  24. Lachmann, H.J., B. Sengul, T.U. Yavuzsen, et al. 2006. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45: 746–750.

    Article  CAS  Google Scholar 

  25. Ozen, S., B. Balci, S. Ozkara, et al. 2002. Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: Speculations remain? Clinical and Experimental Rheumatology 20(Suppl 26): S57–S58.

    PubMed  CAS  Google Scholar 

  26. Snelgrove, T., S. Lim, C. Greenwood, et al. 2007. Association of toll-like receptor 4 variants and ankylosing spondylitis: A case-control study. The Journal of Rheumatology 34: 368–370.

    PubMed  CAS  Google Scholar 

  27. van der Graaf, C.A., M.G. Netea, S.A. Morré, et al. 2006. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. European Cytokine Network 17: 29–34.

    PubMed  Google Scholar 

  28. Emingil, G., A. Berdeli, H. Baylas, et al. 2007. Toll-like receptor 2 and 4 gene polymorphisms in generalized aggressive periodontitis. The Journal of Periodontology 78: 1968–1977.

    Article  CAS  Google Scholar 

  29. Saatçi, U., S. Ozen, S. Ozdemir, A. Bakkaloglu, N. Besbas, R. Topaloglu, and S. Arslan. 1997. Familial Mediterranean fever in children: Report of a large series and discussion of the risk and prognostic factors of amyloidosis. European Journal of Pediatrics 156: 619–623.

    Article  PubMed  Google Scholar 

  30. Yalçinkaya, F., N. Cakar, B. Acar, et al. 2007. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: A case control study. Rheumatology International 27: 517–522.

    Article  PubMed  Google Scholar 

  31. Duzova, A., A. Bakkaloglu, N. Besbas, et al. 2003. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clinical and Experimental Rheumatology 21: 509–514.

    PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Dokuz Eylül University Medical Faculty, İzmir, Turkey

    Alper Soylu, Mehmet Türkmen, Belde Kasap Demir, Ayfer Ülgenalp & Salih Kavukçu

  2. Department of Internal Medicine, Dokuz Eylül University Medical Faculty, İzmir, Turkey

    Halil Ateş & Mehmet Tunca

  3. Department of Medical Biology, Dokuz Eylül University Medical Faculty, İzmir, Turkey

    Sultan Cingöz & Meral Sakızlı

  4. Department of Nephrology, Atatürk Training and Research Hospital, İzmir, Turkey

    Mustafa Cirit & Rıfkı Ersoy

Authors
  1. Alper Soylu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halil Ateş
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sultan Cingöz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehmet Türkmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Belde Kasap Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mehmet Tunca
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Meral Sakızlı
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mustafa Cirit
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rıfkı Ersoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ayfer Ülgenalp
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Salih Kavukçu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alper Soylu.

Additional information

The study was supported by TUBITAK (Scientific and Technological Research Council of Turkey).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soylu, A., Ateş, H., Cingöz, S. et al. TLR Polymorphisms in FMF: Association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) Polymorphisms and Myeloid Cell TLR-2 and TLR-4 Expression with the Development of Secondary Amyloidosis in FMF. Inflammation 34, 379–387 (2011). https://doi.org/10.1007/s10753-010-9245-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-010-9245-9

KEY WORDS

Search

Navigation